GB1531091A - Pharmaceutical combination preparations - Google Patents

Pharmaceutical combination preparations

Info

Publication number
GB1531091A
GB1531091A GB144/76A GB14476A GB1531091A GB 1531091 A GB1531091 A GB 1531091A GB 144/76 A GB144/76 A GB 144/76A GB 14476 A GB14476 A GB 14476A GB 1531091 A GB1531091 A GB 1531091A
Authority
GB
United Kingdom
Prior art keywords
alkyl
carbamoyl
lower alkyl
ureido
optionally substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB144/76A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of GB1531091A publication Critical patent/GB1531091A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

1531091 Pharmaceutical preparations CIBA GEIGY AG 5 Jan 1976 [6 Jan 1975] 00144/76 Heading A5B Pharmaceutical preparations useful as hypnotics for inducing and prolonging sleep and for releiving sleep disorders contain as pharmacological active compounds a compound of the formula: wherein Ar 1 represents a monocyclic or polycyclic, carbocyclic or heterocyclic radical which contains at least one ring of aromatic character and which is bonded to the oxygen atom via a ring carbon atom, said radicals being unsubstituted or substituted by one or two substituents selected from lower (i.e. C 1-7 ) alkyl, lower alkenyl or lower alkinyl, said lower alkyl, lower alkenyl or lower alkinyl being optionally substituted by lower alkoxy, lower alkylthio or halogen, carboxy, lower alkoxycarbonyl, carbamoyl, N-lower alkylated carbamoyl, amino, lower alkanoylamino, lower alkoxy-carbonylamino, ureido, N-lower alkyl-ureido, N', N'-di-lower alkyl-ureido or lower alkylsulphonylamino, or substituted by one or two substituents selected from monocyclic or polycyclic cycloalkyl, hydroxyl, lower alkoxy, lower alkenyloxy, lower alkinyloxy, mercapto, lower alkylthio, lower alkenylthio, halogen, lower alkanoyloxy, lower alkanoyl, lower alkoxycarbonyl, carbamoyl, N-lower alkylcarbamoyl, N, N-di-lower alkylcarbamoyl, cyano, nitro, amino, lower alkanoylamino, lower alkoxycarbonylamino, ureido, N'-lower alkyl-ureido, N', N'-di-lower alkyl-ureido, lower alkylsulphonylureido, lower alkyl sulphonylamino, N-lower alkylamino or N, N-di-lower alkylamino, optionally unsubstituted N, N-lower alkyleneamino, N, N-azalower alkyleneamino, N, N-oxa-lower alkylene-amino or N, N-thia-lower alkyleneamino, R 1 denotes lower alkyl, lower alkenyl, lower alkinyl, cycloalkyl or phenyl-lower alkyl, said lower alkyl, lower alkenyl, lower alkinyl or cycloalkyl being optionally substituted by lower alkyl, phenoxy or pyridyloxy optionally substituted by carbamoyl, N-lower alkylcarbamoyl or N, N-di-lower alkyl-carbamoyl, or optionally substituted by carboxyl, lower alkoxycarbonyl carbamoyl, N-lower alkylcarbamoyl, N, N-di-lower alkyl carbamoyl or cyano, said phenyl-lower alkyl being optionally substituted in the aromatic part by carboxyl, lower alkoxycarbonyl, carbamoyl, N- lower-alkyl carbamoyl or N, N-lower alkyl carbamoyl, R 2 represents hydrogen, lower alkanoyl or benzoyl, or a compound of the formula: wherein R 1 and R 2 have the meanings defined under formula (I), Ar 2 represents a monocyclic or polycyclic carbocyclic radical which contains at least one ring of aromatic character, said monocyclic or polycyclic carbocyclic radical being unsubstituted or substituted as defined under formula (I) and R 3 denotes hydrogen or lower alkyl, or a salt of such compounds, which can be used pharmaceutically, as a beta-receptor-blocking active compound, and L-tryptophan or a non- toxic salt thereof which can be used pharmaceutically. The preparations may be administered orally, rectally or parenterally in the form of tablets, dragÚes, capsules, suppositories and solutions.
GB144/76A 1975-01-06 1976-01-05 Pharmaceutical combination preparations Expired GB1531091A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH7275 1975-01-06

Publications (1)

Publication Number Publication Date
GB1531091A true GB1531091A (en) 1978-11-01

Family

ID=4178653

Family Applications (1)

Application Number Title Priority Date Filing Date
GB144/76A Expired GB1531091A (en) 1975-01-06 1976-01-05 Pharmaceutical combination preparations

Country Status (13)

Country Link
JP (1) JPS5191336A (en)
AU (1) AU500434B2 (en)
BE (1) BE837295A (en)
CA (1) CA1063026A (en)
DE (1) DE2600070A1 (en)
ES (1) ES444083A1 (en)
FR (1) FR2296414A1 (en)
GB (1) GB1531091A (en)
IE (1) IE42230B1 (en)
IL (1) IL48786A (en)
NL (1) NL7600044A (en)
NZ (1) NZ179621A (en)
ZA (1) ZA7627B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4433004A (en) * 1979-07-11 1984-02-21 Tokyo Shibaura Denki Kabushiki Kaisha Semiconductor device and a method for manufacturing the same

Also Published As

Publication number Publication date
IL48786A (en) 1978-12-17
BE837295A (en) 1976-07-05
CA1063026A (en) 1979-09-25
NZ179621A (en) 1978-04-28
DE2600070A1 (en) 1976-07-15
JPS5191336A (en) 1976-08-10
ES444083A1 (en) 1977-05-01
ZA7627B (en) 1976-12-29
FR2296414B1 (en) 1981-12-31
IE42230L (en) 1976-07-06
AU500434B2 (en) 1979-05-24
IL48786A0 (en) 1976-03-31
AU1000376A (en) 1977-07-14
IE42230B1 (en) 1980-07-02
FR2296414A1 (en) 1976-07-30
NL7600044A (en) 1976-07-08

Similar Documents

Publication Publication Date Title
EP0144986A3 (en) Indole-3-carboxamide derivatives
EP0326307A3 (en) Novel pyridazinone derivatives and pharmaceutical preparations containing them
ES8705371A1 (en) Aminopropanol derivatives, process for their preparation, their use and medicines containing them.
GB1342520A (en) Alpha-alkyl-substituted benzyl or thenyl-benzyloxy derivatives of amines
GB1531091A (en) Pharmaceutical combination preparations
GB1352257A (en) Pyridyltriazoles their preparation and compositions containing them
GB1519210A (en) Antiarrythmic compositions containing pyrrolidinyl derivatives
GB1322451A (en) 3-amino-5-benzyl-1,2,4-oxadiazoles
GB1364284A (en) Acylaminophyrrolidinone derivatives their preparation and pharma ceutical compositions containing them
BE881834A (en) DRUGS AND PHARMACEUTICAL PREPARATIONS WITH CYTOSTATIC ACTIVITY
GB1131164A (en) Novel halogen-substituted tetrahydroquinazoline derivatives, their preparation and compositions containing them
GB1280290A (en) Novel derivatives of benzhydrylpiperazine, their process of preparation and their therapeutic application
GB1252975A (en)
NO894325L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PYRROLIDINE DERIVATIVES.
GB1332697A (en) Benzodiazepine derivatives
ES2001590A6 (en) Hydrogenated pyridine derivatives.
ES8500619A1 (en) Eburnane-oxime derivatives
GB1293691A (en) TREATMENT OF MAREK'S DISEASE WITH p-AMINO-p'-UREIDODIPHENYL SULFONE
ES8308332A1 (en) Phospholipid derivatives, process for preparation thereof and pharmaceutical composition of the same.
KR880003624A (en) Novel sinerzist pharmaceutical compositions and uses and preparations thereof
GB1191443A (en) Quinoline Derivatives
GB1330930A (en) Thiazole derivatives and a process for the manufacture thereof
GB1390091A (en) 4-4-biphenylyl-butyric acid derivatives
GB1346456A (en) Organic acid 2,6-disubstituted phenyl hydrazides
GB1505518A (en) Pyrazole derivatives

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee